Current price is less than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

For the year ended December 2021, Access Healthcare had revenues of Rs 25 crore and a profit after tax of Rs 9.4 crore. The company has no debt on its books.

Marksans Pharma acquires Dubai-based Access Healthcare to expand in MENA region

Marksans Pharma signed a share purchase agreement to acquire a 100% stake in Access Healthcare for Medical Products L.L.C, a Dubai-based front-marketing and promotion company for a cash consideration of AED 13 million.

Marksans Pharma acquires Dubai-based Access Healthcare for Rs 27 cr

In the UAE market, the company supplies products through the Dubai Health Authority (DHA).

Marksans Pharma to acquire 100% stake in Dubai-based Access Healthcare for Medical Products

Buzzing stocks: Sun Pharma, Dilip Buildcon, Wipro, Edelweiss Financial, SIS, Tata Power, Hero MotoCorp, BPCL, MEP Infrastructure, Marksans Pharma

Stocks that will see action on February 23

Marksans Pharma intimated that UK MHRA has granted market authorisation to the company’s wholly-owned subsidiary, Bell Sons & Co. (druggists) for Bells Healthcare All in One Oral Solution.

Marksans Pharma announces UK MHRA nod for Bells Healthcare All in One Oral Solution

Arihant Capital is bullish on Marksans Pharma has recommended buy rating on the stock with a target price of Rs 86 in its research report dated February 16, 2022.

Buy Marksans Pharma; target of Rs 86: Arihant Capital

Marksans Pharma advanced 3.33% to Rs 63.70 after the company announced the receipt of final approval from US Food & Drugs Administration for its abbreviated new drug application (ANDA) for over the counter (OTC) Cetirizine Hydrochloride Tablets.

Marksans Pharma gains on US FDA nod for Cetirizine Hydrochloride tablets

It is indicated for the treatment of the perennial allergic rhinitis including sneezing, rhinorrhea, postnasal discharge, watery eyes, running nose. The product will be marketed under store brand labels and is comparable to the brand Zyrtec.

Marksans Pharma receives USFDA approval for Cetirizine Hydrochloride Tablets

The company will manufacture the products at its UK MHRA approved state-of-the-art oral dosage facility located in Goa, India.

Marksans Pharma stocks skyrocket 6% after UK MHRA approves Loperamide 2mg Hard Capsules

Check out the stocks that will be in focus during trade today based on recent and latest news developments.

Top stocks in focus: Star Health, Marksans Pharma, Weizmann, HFCL, Bajaj Electricals

According to reports, Marksans will manufacture the products at its UK MHRA approved state-of-the-art oral dosage facility in Goa.

Marksans Pharma jumps 8%; arm gets UK MHRA nod for Loperamide capsule

Marksans Pharma Limited is a pharmaceutical company, which is engaged in the research, manufacturing and marketing of generic pharmaceutical formulations.

Marksans Pharma Ltd

Marksans Pharma Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Marksans Pharma acquires Dubai-based Access Healthcare to expand in MENA region

Marksans Pharma acquires Dubai-based Access Healthcare for Rs 27 cr

Marksans Pharma to acquire 100% stake in Dubai-based Access Healthcare for Medical Products

Stocks that will see action on February 23

Marksans Pharma announces UK MHRA nod for Bells Healthcare All in One Oral Solution

Buy Marksans Pharma; target of Rs 86: Arihant Capital

Marksans Pharma gains on US FDA nod for Cetirizine Hydrochloride tablets

Marksans Pharma Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Marksans Pharma acquires Dubai-based Access Healthcare to expand in MENA region

Marksans Pharma acquires Dubai-based Access Healthcare for Rs 27 cr

Marksans Pharma to acquire 100% stake in Dubai-based Access Healthcare for Medical Products

Stocks that will see action on February 23

Marksans Pharma announces UK MHRA nod for Bells Healthcare All in One Oral Solution

Buy Marksans Pharma; target of Rs 86: Arihant Capital

Marksans Pharma gains on US FDA nod for Cetirizine Hydrochloride tablets

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock